Investment26 Dec 2025, 06:52 pm
SMS Pharmaceuticals Invests INR 3.99 Crore in Subsidiary SMS Peptides, Increasing Stake to 99.99%
AI Summary
SMS Pharmaceuticals Ltd. has invested INR 3.99 Crore in its subsidiary, SMS Peptides Private Limited, by subscribing to its rights issue. This investment has increased the company's stake in SMS Peptides from 99.98% to 99.99%. SMS Peptides is a pharmaceutical company incorporated in November 2024 and is currently in the implementation stage, with no revenue operations as of yet. The transaction is at arm's length and does not involve any governmental or regulatory approvals.
Key Highlights
- SMS Pharmaceuticals invests INR 3.99 Crore in subsidiary SMS Peptides
- Investment increases SMS Pharmaceuticals' stake in SMS Peptides to 99.99%
- SMS Peptides is a pharmaceutical company incorporated in November 2024
- The transaction is at arm's length
- No governmental or regulatory approvals required for the acquisition